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Abstract 
 
Many people are concerned about their family history of breast cancer, and are anxious 
about the possibility of developing breast cancer themselves. The majority of these 
people are likely not to be at significantly increased risk of developing inherited breast 
cancer. All women are at risk of developing sporadic breast cancer, and this risk increases 
with age. The UK National Institute of Health and Clinical Excellence has published 
guidance for the National Health Service on the management of familial breast cancer. 
That guidance lays down clear criteria for categorising risk level and the appropriate 
management options. We have developed a user-friendly computer programme named 
OPERA (Online Patient Education and Risk Assessment) which captures the 
individuality of the user’s situation in a comprehensive way, and then produces 
personalised information packages, building on the theoretical framework of 
argumentation developed by Stephen Toulmin (1958). We will test this programme in a 
series of pilot studies commencing in Spring 2007. This paper describes the progress of 
this project to date and focuses on the design of the programme.  
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1. Background  
 
Cancer is an emotive word within the general population, but it causes even more anxiety 
amongst individuals with previous experience of the diagnosis of cancer in other 
members of the family. Breast cancer has a particularly high political and media profile, 
and there appears to be a real, but probably exaggerated fear, of developing breast cancer 
in family members of women who have already developed the disease. 
Several sets of guidelines have been published which outline the approximate risk to 
relatives of developing inherited breast cancer, depending on the strength of their family 
history of breast and ovarian cancer. All these guidelines, which differ on minor details 
rather than on any issues of important substance, concentrate on informing those 
individuals considered to be at high, or significantly increased risk. These individuals 
may be offered access to genetic testing or to programmes of more intensive screening to 
identify early disease. 
However, individuals who have what is considered to be a significant family history of 
breast cancer only constitute a small minority of all those who have some family history 
of breast cancer. The majority of women who have a relative with breast cancer are not at 
significantly increased risk of developing inherited breast cancer themselves. Their risk 
of developing non-genetic or sporadic breast cancer increases with age and other lifestyle 
factors in exactly the same fashion as women who have no family history of disease. 
This situation therefore represents a real challenge to healthcare professionals with 
expertise in the communication of clinical information to non-expert audiences. On one 
side, the important clinical message is that the risk of developing breast cancer because of 
the family history of disease is not very high compared to those rare individuals with a 
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very strong family history. On the other side, the important message is that ALL women 
are at risk of developing breast cancer, the biggest known risk factor of which is 
increasing age. 
In Europe the lifetime risk of developing breast cancer is around 9-11%, making breast 
cancer the most common female cancer.  In the UK this is considered such a significant 
problem in public health terms, that the National Health Service (NHS) offers regular 
breast screening to all women once they reach the age of 50. This programme is one of 
only two fully funded adult cancer screening programmes offered from the public purse. 
Considerable resources have been devoted to establishing and running this programme, 
including extensive media campaigning to encourage as many women as possible from 
all backgrounds to attend for free breast screening 
 
2. A difficult problem 
The aim of giving accurate information is to reduce anxiety, which is perceived by an 
external observer to be inappropriate and therefore in some way unnecessary. 
Information, which reduces appropriate anxiety, would be considered misleading. The 
whole issue of appropriate anxiety, regarding the risk of breast cancer, is driven, at least 
in part, by the provision of a state sponsored mammographic screening programme from 
the age of 50, with uptake being considered one of the important quality indicators of the 
programme.  
One important goal of a programme such as Cancerbackup’s OPERA, which aims to give 
individuals information about their risk of developing inherited breast cancer, must be to 
reduce the anxiety of those who do not have a significant family history of disease down 
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to the level of those without any family history. However, such women should still be 
concerned enough about every woman’s risk of developing breast cancer to join the 
National Screening Programme when they are 50. 
An important distinguishing factor between inherited and sporadic breast cancer is the 
average age of onset. In general, inherited breast cancer develops at a younger age than 
sporadic breast cancer. Specifically, a carrier of the BRCA1 gene mutation has a 50% 
chance of developing breast cancer before the age of 50; in the normal population the risk 
of developing breast cancer below 50 years of age is 1%. The provision of state 
sponsored breast screening in the UK from the age of 50 may be a convenient, although 
artificial, discriminator which helps convey the important messages.  
The real challenge which OPERA faces is in informing those who are at low risk of 
developing inherited breast cancer; balancing the good news of low inherited risk with 
the ever present risk of sporadic breast cancer which every woman faces.      
 
3. The ingredients available 
The National Institute for Health and Clinical Excellence (NICE) examines all the 
available evidence, and offers guidance to the National Health Service in the UK. It has 
no powers of implementation, but the guidance produced on those subjects, which have 
been referred to NICE, is considered authoritative. NICE produced guidance on the 
Management of Familial Breast Cancer in 20041, which sets out criteria, based on 
strength of family history, for triaging individuals into three different risk groups: high, 
moderate and low. Different management options are available within the National 
                                                 
1 Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, 
secondary and tertiary care. (Clinical Guideline 041, partially updated in October 2006) 
www.nice.org.uk 
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Health Service for each group, although there is general agreement that the options 
available to the low risk group are very limited. As noted above, most guidelines 
concentrate on informing the high and moderate risk groups of the available options, but 
at least the NICE guidance provides authoritative, and generally accepted, criteria for 
determining the low risk group. 
Cancerbackup is the leading provider of information for cancer patients, their relatives 
and carers in the UK. In collaboration with University College London, Cancerbackup 
secured a grant from the UK Department of Health to fund a project on the provision of 
patient information about cancer genetics. The first part of this project involved the 
development of a booklet on cancer genetics for families who would be offered genetic 
testing within the NHS. This booklet won an award for clarity from the British Medical 
Association. Subsequent work involved the production of five different leaflets for 
patients with a family history of different cancers, which would not be considered strong 
enough to warrant the offer of genetic testing within the NHS; the so-called low risk 
group, although it is widely accepted that this is a misleading label for that group. These 
leaflets have been immensely popular with over 100,000 already distributed within the 
UK. 
University College London is the original college of the University of London, and was 
founded in 1826, as the third university in England after Oxford and Cambridge. UCL 
has a long and distinguished history of research into human genetics, beginning with Sir 
Francis Galton, a nephew of Charles Darwin. The Galton laboratory, founded in his 
memory was considered to be the best place in the world to study human genetics for 
most of the 20th century. The Institute of Communication and Health of the University of 
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Lugano is one of only three healthcare communication laboratories in Europe. In 
partnership with the Technology Enhanced Communication Laboratory of the same 
University, researchers have become expert in the application of advanced IT solutions to 
facilitate communication within healthcare. 
 
4. Project OPERA; Online Patient Education and Risk Assessment 
Cancerbackup’s OPERA for inherited breast cancer is a user friendly computer 
programme which invites the user to enter details of their personal history of breast 
and/or ovarian cancer and the details of their family history of breast and/or ovarian 
cancer. The programme also gathers some information on age, sex, ethnicity and history 
of other cancers that are relatively rare but may be important in assessing an individual’s 
risk of developing inherited breast cancer. The user is led through the process by a series 
of clear unambiguous questions. Once the information has been gathered by the 
programme it is summarised in the form of a simple table for the user to verify. 
Rules for risk assessment and clinical management, based on the Clinical Guideline on 
Familial Breast Cancer (Clinical Guideline 041, partially updated in October 2006, 
www.nice.org.uk) published by the National Institute for Health and Clinical Excellence 
(NICE), are applied to the information given by the user.  A personalised information 
package is then presented to the user explaining the risk assessment process, and the 
various management options that would be expected to be available to the user. The user 
is also offered access to information which is not directly relevant to them, but may 
interest them. 
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Users are warned that alterations in their personal or family history may significantly 
alter the information which is pertinent to them (they are advised to repeat the process if 
this is the case), and they are invited to send their information anonymously to 
Cancerbackup to be used to compile statistics on user profile and frequency of use.  
The final section of the information package contains a list of suggestions as to what the 
user might do next and where to go for further information.  This is regarded as a 
particularly important section, the primary aim of the OPERA being not to cause 
unfounded anxiety, rather to inform and support the user. Furthermore, it is not intended 
that the use of OPERA should bypass a clinical consultation. The intention is to increase 
the user’s understanding of the risk assessment process in the NHS, thereby empowering 
the user to access clinical services appropriately, and to complement those services. 
Structuring the information package so that it is considered by the user to be a useful and 
trustworthy source of information, was one of the challenges facing the team of the 
Institute of Communication and Health of the University of Lugano. As discussed earlier 
in this paper, the challenge of contextualising inherited breast cancer risk in the low or 
near-population risk group was particularly great. 
 
5. Theoretical Approach: Explanations as Arguments 
In the last few years, due an increased availability of genetic tests and a growth in genetic 
counselling, the study of risk communication in the field has produced several important 
contributions [1] [2].Yet, although the issue of delivering information about cancer 
genetics according to people’s level of risk has arisen in the literature [3] [4] [5] and, 
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also, there are several studies on online genetics risk communication [6] [7] [8] [9], the 
issue does not seem to have been addressed in the perspective of our study. 
We acknowledge that there are various risk assessment tools already available online. In 
an attempt to understand the communication strategy adopted by existing risk 
assessments we made a benchmarking analysis of these instruments, aimed at 
highlighting the distinctive features of the applications from the point of view of the 
navigation/interaction and the nature of the contents delivered. There we noted that, 
traditionally, human-system transactions in this sector result in outputs which do not 
explain the reasons for the outputs themselves. Knowledge-based systems do not 
normally justify their conclusions to its users. To give some examples: 
Using a risk assessment for calculating the risk of breast cancer (the real name of the 
instrument is left out for reasons of privacy) the user is invited to answer a set of 
questions. By then clicking on the box titled 'calculate risk', users receive answers of the 
following type: 
Your chance of being diagnosed with breast cancer is estimated to be 29.8% 
within lifetime (to age 90). 
Apart from the presence in this type of messages of percentages, whose usage in risk 
assessment is not without complication [10], the important thing to note is that there is no 
additional content to explain what this percentage means and why it is so. 
Again, another risk assessment tool for genetic breast cancer generates messages of the 
following type: 
Compared to a typical woman of your age, your risk is average. 
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Here, again, there is no indication of how the answers given by the user point to the risk 
classified as average.  
Existing online tools seem to produce answers from authority, where the main claims are 
left unsupported. This lack of support seems to be a critical limitation in the above way of 
delivering risk assessment tests, insofar as users are not given enough information for 
reflecting on the reasons behind their risk levels.  
Within this context, the communication strategy of OPERA was designed using 
argumentation theory. This theory offers a mechanism for supporting the main claims or, 
technically speaking, ‘standpoints’ (van Eemeren) about the information provided and 
options for subsequent action by the user. At the same time, using argumentation in 
delivering health related information may facilitate understanding, helping the user to 
contextualise it in the framework of their individual situation. This may enhance the 
acceptability of the information to the user.  
The classical explanation of the term argumentation is that argumentation is a process of 
giving reasons for taking certain standpoints on issues which are intrinsically problematic 
and which allow different solutions [11] [12] [13]. Two of the authors have shown 
elsewhere that the process of argumentation has consequences on the way people process 
health information [14] [15]. Argumentation offers information to be used as points of 
reference for structuring  decisions. According to the theory of argumentation, it: 
• adds motivators, in Searle’s terms [16], to the internal reasons (factual       
information and intentional) and to other propositionally structured entities such 
as needs, commitments and requirements ,and   
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• stimulates the appraisal of the relative weights of the whole set of motivators in 
arriving at a decision.  
Clearly, the ultimate outcome of the interaction must always take into consideration the 
gap between the deliberative process and the decision itself, as well as between the 
intention-in-action and the actual carrying out of the activity to its completion (Searle 
2001). Individual decisions in terms of behaviour are ultimately affected by a series of 
factors that, as social scientists know well, is very difficult to determine. Argumentation 
is a useful concept to help healthcare workers present information in a manner which 
engenders confidence and acceptance in their listeners, because the listener is presented 
with the motivation behind the information. To use a recent key-concept in health 
research, argumentation has an impact on people’s health literacy [17] by displaying a 
variety of possible actions and enhancing choice among these actions. Translating this 
into human-machine interaction, users' understanding and acceptance of the risk 
assessment information delivered by OPERA will depend on, and may be enhanced by,  
the system explaining its reasoning and thereby justifying its conclusions [18].  
In light of this background, OPERA implements an explanation framework that justifies 
the information given. The central component is an explanation strategy that decides 
what information justifies a claim in the expected direction. The main design criteria for 
OPERA’s information packages are as follows: 
1) the NICE Guideline for the management of familial breast cancer1 forms the 
evidence base for the entire programme.  
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2) The claim indicating the level of risk, and the available management options, 
should make transparent the rules that lead to that claim being made. The 
programme should also offer broader supporting material (e.g. reference to 
medical literature, specific articles and, ultimately the guidelines) and sources of 
personal support (e.g. details of helplines or places where the user may go for 
further help or explanation). 
3) The explanation should include a rebuttal, which aims to ensure that the user does 
not form an incorrect inference from the claim made .   
4) The explanation should contain an indication of the confidence with which the 
claim is made. In dealing with inherited cancer risk, in particular, it has to be clear 
that should the personal or family history of the user change, s/he would have to 
repeat the assessment. 
 
The structure and design of OPERA’S information packages are based on the scheme that 
Stephen Toulmin utilised in his theory of reasoning in 1958 [19] (Figure 1). Indeed, we 
note that Toulmin’s structure allows an identification of all the elements which are 
relevant for implementing the proposed model of risk communication. Central to his 
theory is a six-element structure that can be use to generate the explanations. This 
structure reads as follows: 
 
1. Data: the evidence, facts, background data and information we use to make the 
claim; 
 13
2. Warrant: the component of the argument that establishes the logical connection 
between the data and the claim, acting as the reasoning process used by the 
speaker to arrive at the claim; 
3. Backing: the grounding material that supports the warrant in the argument; 
4. Rebuttal: an exception or dissociation of aspects for which the claim presented is 
not valid; 
5. Qualifier: the verbalization of the relative strength of an argument; 
6. Claim: the assertion or conclusion put forward for general acceptance. 
 
Figure 1, here 
 
The phenomenon of risk perception resistance is known in the literature [20]. This aspect 
is particularly critical when users have reasons for using OPERA which require answers 
beyond the simple explanation ‘You do not appear to have any significant personal or 
family history (according to the national guidelines for risk assessment)’.  
In the next paragraph we will illustrate how the theoretical design features of the 
explanations delivered by OPERA are to be implemented. 
 
6. OPERA’s Information Packages 
6.1From Theory to Practice (and Back Again) 
To give empirical value to an important aspect of our approach, we made a content 
analysis of letters written by genetic counsellors to their patients to inform the 
construction of the personalised information packages within OPERA. These letters are 
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tailored documents summarizing services and information provided to the patient which 
the genetic counsellor writes after a face to face consultation. In the analysis, we noted 
that many counsellors instinctively support any statements they make with an 
explanation, perhaps subconsciously following the argumentation theory. This is 
demonstrated in the extract of one of the letters we analysed, which is shown in figure 2. 
 
Figure 2, here 
 
Here we can see that the counsellor states that the cancer was probably sporadic 
(not due to an inherited genetic mutation) on the basis of the data given by the 
patient (namely, the daughter-in-law who is not a blood relative of the patient and 
the aunt who developed breast cancer in her 60s), backing up this statement by 
quoting some broad pointers as specified by clinical guidelines (points 1, 2 and 3 in 
the letter).  
 
6.2 Applying the general theory to the construction of the personalised 
information packages 
Figure 3 outlines the specific application of Toulmin’s theory to the information packages 
within OPERA. The initial claim is represented by an indication of the risk level, with the 
secondary claim being represented by a description of the options available. Relevant 
medical literature and scientifically authoritative sources (Warrant) and reference to 
guideline knowledge base (Backing) provide the basis for the claims made. If data is 
missing, or incorrect (Rebuttal), then the claim is rendered invalid. The claims hold for 
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the specific context of inherited breast cancer, as outlined within the guidance provided 
by NICE (Qualifier).  
 
Figure 3, here 
 
The above scheme results in the information package for OPERA users composed of 5 
parts, namely: 
 
1. Your present situation: an indication of the risk level (e.g. Your answers suggest 
that there is a slightly increased chance that there is a faulty breast cancer gene 
in your family); 
2. Explanation: the justification of ‘your present situation’ on the basis of the data 
inserted and national guidelines; 
3. What next? a description of possible options which may be offered;  
4. What might change your current situation 
5. How confident can you be? stating that the information package is based on the 
NICE Guideline. Other sources of support are also offered. 
 
As stated earlier, users who, based on their answers to the questions, do not appear to be 
at increased risk, are asked a question to try to elucidate their reason(s) for using OPERA. 
To help formulate this question, a content analysis of  media articles published in British 
newspapers in the last 12 months was performed in order ascertain factors which  
 16
influence people’s understanding and worries about breast cancer in the family. Three 
main categories of influence came to light: 
 
 Influence from healthcare workers;  
 Influence from relatives and friends; 
 Influence from the media. 
 
This question, which seeks to discover the user’s motivation for accessing the tool, will 
no doubt require refinement on the basis of results from the three pilot studies of OPERA 
(using volunteers) to be conducted over the next 12 months. 
 
7. Conclusion  
We have developed a user friendly programme to present a personalised information 
package to individuals who are concerned about inherited breast cancer risk. This 
programme gathers personal medical data and information about relatives who have 
developed cancer, and then produces the personalised information based on guidance 
produced for the National Health Service by the National Institute for Health and Clinical 
Excellence. In designing OPERA, much attention has been paid to creating a programme 
that seeks to capture the individuality of the user’s situation in a comprehensive way.  
This project investigates the possibility of building a more human-like automated system 
by relying on insights from humanistic disciplines.  
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The intention is to test this framework in 3 pilot studies (respectively with samples of 20, 
100 and 300 users) over the next 12 months. This will enable us to understand the actual 
impact on the user of information presented in this way.  
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